Can Elbit Systems (ESLT) Stock Reach $870?

Key Takeaways

• The central target used here is $870, the arithmetic mean of the four most recent, individually attributable analyst price targets reviewed.
• With the latest close near $744.33, reaching $870 would require roughly a 17% advance — a substantial move.
• The individual targets span a wide $790 to $960 range, reflecting genuine disagreement about valuation after a steep pullback from the 52-week high.
• Supportive factors include strong recent earnings beats, rising revenue, and robust global defense demand.
• The main risks are a premium valuation, ongoing target cuts from Wall Street, and a share price trading below its 200-day average.

Analyst Price Targets and Consensus View

Elbit Systems Ltd. (ESLT), the Israeli defense-electronics company, is covered by a relatively small group of sell-side analysts. Reviewing the most recent, individually identifiable targets from four major firms gives a range of roughly $790 to $960. The most recent figures include Jefferies (Sheila Kahyaoglu) at $790 with a Hold rating, J.P. Morgan (Seth Seifman) at $885 with a Neutral rating, Morgan Stanley at $845 with a Hold rating, and Bank of America at $960 with a Buy rating. The arithmetic mean of these four targets is $870.

What stands out is how much analysts have been trimming their numbers. Bank of America cut its target from $1,075 to $960, J.P. Morgan from $950 to $885, Morgan Stanley from $978 to $845, and Jefferies from $880 to $790. These downward revisions — despite Buy and Hold ratings — signal that several firms view the shares as fairly valued or slightly overvalued after a long rally, rather than clearly cheap. There is no published "Strong Sell" consensus; the debate is between one more bullish voice and a cautious center.

Current Market Position and Path Toward the Target

The stock last traded near $744.33, well off its 52-week high of about $1,016 but far above its 52-week low near $453. Reaching the $870 central target would require a gain of approximately 17%, which qualifies as a substantial move for a large-cap defense name in a short window.

The path matters as much as the distance. Elbit Systems has delivered accelerating fundamentals: trailing-twelve-month revenue of about $8.55 billion (up roughly 14% year over year), net income of about $636 million (up over 50%), and EPS (earnings per share) of about $13.27. In its most recent quarter, the company beat consensus estimates on both the top and bottom lines. Continued execution on its sizable order backlog and new contract wins, such as a recently announced $235 million European defense award, would be central to any move toward $870.

What Could Support a Move Toward the Target

• Earnings momentum: EPS and revenue have grown sharply, and the next report is expected to show EPS of roughly $3.87 versus $3.35 a year earlier.
• Defense demand: Elevated global security spending continues to underpin Elbit's order flow across its airborne, land, and C4ISR (command, control, communications, computers, intelligence, surveillance, and reconnaissance) product lines.
• Backlog visibility: A substantial order book provides multi-year revenue visibility that could support a higher multiple if growth stays on track.
• Balance-sheet flexibility: Low leverage leaves room for acquisitions, buybacks, or higher shareholder returns alongside its modest dividend.

What Could Prevent the Target From Being Reached

• Valuation: The stock trades near a P/E (price-to-earnings) ratio of roughly 56 on trailing earnings, leaving little room for disappointment if growth cools.
• Analyst target cuts: The recent pattern of downward revisions suggests some firms already see limited upside from current levels.
• Technical damage: Trading below the 200-day average can weigh on investor sentiment and invite continued selling pressure.
• Execution and geopolitical risk: Supply-chain constraints, program delays, or a slowdown in defense budgets could pressure both earnings and the multiple.

Technical Levels and Market Structure

The shares remain in a clear longer-term uptrend, having more than doubled off the 52-week low, but the near-term structure is more cautious. The 52-week high near $1,016 is the most durable resistance reference, while the 200-day moving average near $797 now sits above the price and acts as near-term resistance. A sustained move back above that average would likely be needed to build momentum toward the $870 area. On the downside, the 52-week low near $453 and the psychological $700 level are the key support references investors are watching.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms vary and do not publish a uniform timetable. Investors should monitor the company's next earnings release, expected in November 2026, along with guidance and any updates to its order backlog. Also worth watching are further analyst rating or target changes, sector-wide defense-budget developments, and whether the stock can reclaim its 200-day moving average.

AI Daily Buy/Sell Signals

For traders looking to track shifting momentum in ESLT and the broader market, AI Daily Buy/Sell Signals offers a data-driven complement to fundamental research. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. It can help traders discover opportunities, monitor open positions, and spot emerging trends more efficiently than manual chart review alone. Explore AI Daily Buy/Sell Signals to see how AI-driven signals fit into your own workflow.

Final Assessment

Reaching $870 would require Elbit Systems to climb roughly 17% from its recent level — a substantial but not extreme move for a company delivering strong earnings growth and benefiting from elevated defense spending. The central target is not a guarantee; it is simply the average of the latest analyst price targets, which span a wide $790 to $960 range and have been trending lower as firms reassess a premium valuation. Strong backlog, robust demand, and continued earnings beats provide the clearest support, while a rich multiple, a price below its 200-day average, and repeated target reductions are the principal obstacles. Investors should watch the November earnings report and any shift in analyst revisions to gauge whether the shares are building the foundation required to approach that level.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations